The New York Regional Center for Diabetes Translation Research (CDTR) announces the availability of Pilot and Feasibility (P&F) awards (up to $25,000 annually for up to two years) for new projects that address a diabetes-related translational research question. Translational projects related to diabetes prevention or control are eligible if they are use methodologies such as: community-based participatory research, implementation or dissemination science, natural experiment methods, as well as quantitative or qualitative methods to assess novel interventions and/or technologies to improve diabetes prevention or diabetes care and outcomes at the individual, group or population level. The CDTR website http://www.newyorkregionalcdtr.org provides information about resources and consultation services to support diabetes-related translational research. The P&F funds are intended to enable CDTR member investigators to generate preliminary data for seeking extramural funding of their project. P&F funds are not intended to support or supplement ongoing diabetes research programs. Recipients must hold the rank of Assistant Professor or higher at the time of the award.
ELIGIBILITY (in order of priority): This program is designed to support:
APPLICATION: A proposed P&F study should present a testable hypothesis and clearly delineate the question being asked, detail the procedure to be followed, and discuss how the data will be analyzed. The budget for the first year (of a possible two-year funding period) can be up to $25,000. Requests for institutional indirect costs are prohibited; salary support for the investigator is to be minimal (5%), except when a request has been pre-approved by the directors before submission. Renewal for a second funding year is contingent on adequate progress. Recipients must submit a brief progress report and present their research progress at a “Works in Progress” Seminar during the year of funding.
***It is required for applicants to submit a brief Letter of Intent so that the CDTR leadership can indentify reviewers in a timely manner and can provide feedback if the proposed topic is not responsive to the intent of this call for proposals. This Letter of Intent is due on July 1, 2017 and should be emailed as an attachment to Jennifer.Lukin@einstein.yu.edu.
No internal grant forms or approval signatures are necessary in order to submit an application. However, if IRB approval is needed for protection of human subjects, then applicants should apply for that approval at the time the proposal is submitted. Submit your application electronically as an e-mail attachment to Jennifer.Lukin@einstein.yu.edu by July 21, 2017.
Application must include an abstract, budget, a research plan that does not exceed 5 pages, other support data, and NIH biosketches for all key personnel. Provide these components as a single Word or PDF document. If PDF format is used, also include a copy of the abstract as a Word document. Please use the NIH PHS 398 grant application forms which can be downloaded from the NIH website: http://grants1.nih.gov/grants/funding/phs398/phs398.html.
The start date for funding of successful applications is anticipated to be September 1, 2017.
Questions concerning this program should be directed to NY Regional CDTR Directors:
Judith.Wylie-Rosett@einstein.yu.edu or Elizabeth.Walker@einstein.yu.edu